1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine

C161H330N20O12 — CID 165089282

IUPAC1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine
SMILESCC(C)(C)CCC(=O)N1CCN(CCOC(C)(C)C)CC1.CC(C)(C)CNC(=O)CN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)N1C[C@@H]2C[C@H]1CN2C(C)(C)C.CC(C)(C)N1C[C@H]2C[C@@H]1CN2C(C)(C)C.CC(C)(C)NCCCN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)NCCN1CCN(C(C)(C)C)CC1.CC(C)(C)NCCN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)OCCC1CC2(C1)CC(CCOC(C)(C)C)C2.CC(C)(C)OCCC1CC2(C1)CC(CCOC(C)(C)C)C2.CC(C)(C)OCCN1CCN(CCOC(C)(C)C)CC1
InChIInChI=1S/2C19H36O2.C17H35N3O2.C17H37N3O.C17H34N2O2.C16H35N3O.C16H34N2O2.C14H31N3.2C13H26N2/c2*1-17(2,3)20-9-7-15-11-19(12-15)13-16(14-19)8-10-21-18(4,5)6;1-16(2,3)14-18-15(21)13-20-9-7-19(8-10-20)11-12-22-17(4,5)6;1-16(2,3)18-8-7-9-19-10-12-20(13-11-19)14-15-21-17(4,5)6;1-16(2,3)8-7-15(20)19-11-9-18(10-12-19)13-14-21-17(4,5)6;1-15(2,3)17-7-8-18-9-11-19(12-10-18)13-14-20-16(4,5)6;1-15(2,3)19-13-11-17-7-9-18(10-8-17)12-14-20-16(4,5)6;1-13(2,3)15-7-8-16-9-11-17(12-10-16)14(4,5)6;2*1-12(2,3)14-8-11-7-10(14)9-15(11)13(4,5)6/h2*15-16H,7-14H2,1-6H3;7-14H2,1-6H3,(H,18,21);18H,7-15H2,1-6H3;7-14H2,1-6H3;17H,7-14H2,1-6H3;7-14H2,1-6H3;15H,7-12H2,1-6H3;2*10-11H,7-9H2,1-6H3/t;;;;;;;;2*10-,11-/m........10/s1
InChIKeyWKSNABUZTIKTBX-WWPGSNDGSA-N
MW2738.54 g/mol
LogP27.47
Rot. Bonds45

About 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine

1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine (PubChem CID 165089282) has the molecular formula C161H330N20O12 and a molecular weight of 2738.54 g/mol. Its IUPAC name is 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine.

Molecular Properties

Compound Name1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine
PubChem CID165089282
Molecular FormulaC161H330N20O12
Molecular Weight2738.54 g/mol
Exact Mass2736.58
IUPAC Name1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine
SMILESCC(C)(C)CCC(=O)N1CCN(CCOC(C)(C)C)CC1.CC(C)(C)CNC(=O)CN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)N1C[C@@H]2C[C@H]1CN2C(C)(C)C.CC(C)(C)N1C[C@H]2C[C@@H]1CN2C(C)(C)C.CC(C)(C)NCCCN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)NCCN1CCN(C(C)(C)C)CC1.CC(C)(C)NCCN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)OCCC1CC2(C1)CC(CCOC(C)(C)C)C2.CC(C)(C)OCCC1CC2(C1)CC(CCOC(C)(C)C)C2.CC(C)(C)OCCN1CCN(CCOC(C)(C)C)CC1
InChIInChI=1S/2C19H36O2.C17H35N3O2.C17H37N3O.C17H34N2O2.C16H35N3O.C16H34N2O2.C14H31N3.2C13H26N2/c2*1-17(2,3)20-9-7-15-11-19(12-15)13-16(14-19)8-10-21-18(4,5)6;1-16(2,3)14-18-15(21)13-20-9-7-19(8-10-20)11-12-22-17(4,5)6;1-16(2,3)18-8-7-9-19-10-12-20(13-11-19)14-15-21-17(4,5)6;1-16(2,3)8-7-15(20)19-11-9-18(10-12-19)13-14-21-17(4,5)6;1-15(2,3)17-7-8-18-9-11-19(12-10-18)13-14-20-16(4,5)6;1-15(2,3)19-13-11-17-7-9-18(10-8-17)12-14-20-16(4,5)6;1-13(2,3)15-7-8-16-9-11-17(12-10-16)14(4,5)6;2*1-12(2,3)14-8-11-7-10(14)9-15(11)13(4,5)6/h2*15-16H,7-14H2,1-6H3;7-14H2,1-6H3,(H,18,21);18H,7-15H2,1-6H3;7-14H2,1-6H3;17H,7-14H2,1-6H3;7-14H2,1-6H3;15H,7-12H2,1-6H3;2*10-11H,7-9H2,1-6H3/t;;;;;;;;2*10-,11-/m........10/s1
InChIKeyWKSNABUZTIKTBX-WWPGSNDGSA-N
XLogP27.47
TPSA226.40 Ų
H-Bond Donors4
H-Bond Acceptors30
Rotatable Bonds45
Heavy Atoms193
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002738.54
LogP ≤ 527.47
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine?
The IUPAC name of 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine (CID 165089282) is 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine.
What is the SMILES notation for 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine?
The canonical SMILES for 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine is CC(C)(C)CCC(=O)N1CCN(CCOC(C)(C)C)CC1.CC(C)(C)CNC(=O)CN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)N1C[C@@H]2C[C@H]1CN2C(C)(C)C.CC(C)(C)N1C[C@H]2C[C@@H]1CN2C(C)(C)C.CC(C)(C)NCCCN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)NCCN1CCN(C(C)(C)C)CC1.CC(C)(C)NCCN1CCN(CCOC(C)(C)C)CC1.CC(C)(C)OCCC1CC2(C1)CC(CCOC(C)(C)C)C2.CC(C)(C)OCCC1CC2(C1)CC(CCOC(C)(C)C)C2.CC(C)(C)OCCN1CCN(CCOC(C)(C)C)CC1.
What is the InChIKey of 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine?
The InChIKey is WKSNABUZTIKTBX-WWPGSNDGSA-N. The full InChI is InChI=1S/2C19H36O2.C17H35N3O2.C17H37N3O.C17H34N2O2.C16H35N3O.C16H34N2O2.C14H31N3.2C13H26N2/c2*1-17(2,3)20-9-7-15-11-19(12-15)13-16(14-19)8-10-21-18(4,5)6;1-16(2,3)14-18-15(21)13-20-9-7-19(8-10-20)11-12-22-17(4,5)6;1-16(2,3)18-8-7-9-19-10-12-20(13-11-19)14-15-21-17(4,5)6;1-16(2,3)8-7-15(20)19-11-9-18(10-12-19)13-14-21-17(4,5)6;1-15(2,3)17-7-8-18-9-11-19(12-10-18)13-14-20-16(4,5)6;1-15(2,3)19-13-11-17-7-9-18(10-8-17)12-14-20-16(4,5)6;1-13(2,3)15-7-8-16-9-11-17(12-10-16)14(4,5)6;2*1-12(2,3)14-8-11-7-10(14)9-15(11)13(4,5)6/h2*15-16H,7-14H2,1-6H3;7-14H2,1-6H3,(H,18,21);18H,7-15H2,1-6H3;7-14H2,1-6H3;17H,7-14H2,1-6H3;7-14H2,1-6H3;15H,7-12H2,1-6H3;2*10-11H,7-9H2,1-6H3/t;;;;;;;;2*10-,11-/m........10/s1.
What are the key properties of 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine?
1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine has a molecular weight of 2738.54 g/mol, XLogP of 27.47, 45 rotatable bonds, 4 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 1,4-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazine;bis(2,6-bis[2-[(2-methylpropan-2-yl)oxy]ethyl]spiro[3.3]heptane);N-[2-(4-tert-butylpiperazin-1-yl)ethyl]-2-methylpropan-2-amine;(1S,4S)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;(1R,4R)-2,5-ditert-butyl-2,5-diazabicyclo[2.2.1]heptane;4,4-dimethyl-1-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]pentan-1-one;N-(2,2-dimethylpropyl)-2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]acetamide;2-methyl-N-[2-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]ethyl]propan-2-amine;2-methyl-N-[3-[4-[2-[(2-methylpropan-2-yl)oxy]ethyl]piperazin-1-yl]propyl]propan-2-amine is sourced from PubChem (CID 165089282), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).